Literature DB >> 2203578

Problems in pharmacokinetic investigations in patients with HIV infection.

J D Unadkat1, J M Agosti.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2203578     DOI： 10.2165/00003088-199019030-00002

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  22 in total

1.  Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS).

Authors:  D J Schneiderman; D M Arenson; J P Cello; W Margaretten; T E Weber
Journal:  Hepatology       Date:  1987 Sep-Oct       Impact factor: 17.425

2.  Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments.

Authors:  L Resnick; K Veren; S Z Salahuddin; S Tondreau; P D Markham
Journal:  JAMA       Date:  1986-04-11       Impact factor: 56.272

3.  Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

Authors:  D I Abrams; S Kuno; R Wong; K Jeffords; M Nash; J B Molaghan; R Gorter; R Ueno
Journal:  Ann Intern Med       Date:  1989-02-01       Impact factor: 25.391

4.  Odynophagia from aphthous ulcers of the pharynx and esophagus in the acquired immunodeficiency syndrome (AIDS).

Authors:  M C Bach; A J Valenti; D A Howell; T J Smith
Journal:  Ann Intern Med       Date:  1988-08-15       Impact factor: 25.391

5.  Killed Escherichia coli stimulates macrophage-mediated alterations in hepatocellular function during in vitro coculture: a mechanism of altered liver function in sepsis.

Authors:  M A West; G A Keller; F B Cerra; R L Simmons
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

Review 6.  Perspectives on gastrointestinal infections in AIDS.

Authors:  E N Janoff; P D Smith
Journal:  Gastroenterol Clin North Am       Date:  1988-09       Impact factor: 3.806

7.  Non-cryptosporidial diarrhoea in human immunodeficiency virus (HIV) infected patients.

Authors:  G M Connolly; D Shanson; D A Hawkins; J N Webster; B G Gazzard
Journal:  Gut       Date:  1989-02       Impact factor: 23.059

8.  The types of renal disease in the acquired immunodeficiency syndrome.

Authors:  T K Rao; E A Friedman; A D Nicastri
Journal:  N Engl J Med       Date:  1987-04-23       Impact factor: 91.245

9.  Quantification of dideoxycytidine in human plasma by gas chromatography/mass spectrometry.

Authors:  F R Rubio; T Crews; W A Garland; E K Fukuda
Journal:  Biomed Environ Mass Spectrom       Date:  1988-11

10.  Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms.

Authors:  J A Nelson; C A Wiley; C Reynolds-Kohler; C E Reese; W Margaretten; J A Levy
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321
View more
  4 in total

1.  A population pharmacokinetic analysis of nelfinavir mesylate in human immunodeficiency virus-infected patients enrolled in a phase III clinical trial.

Authors:  K A Jackson; S E Rosenbaum; B M Kerr; Y K Pithavala; G Yuen; M N Dudley
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

2.  Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome--a population pharmacokinetic study.

Authors:  S Mouly; G Aymard; J P Tillement; C Caulin; J F Bergmann; S Urien
Journal:  Br J Clin Pharmacol       Date:  2001-06       Impact factor: 4.335

3.  Pharmacokinetics of zidovudine after the initial single dose and during chronic-dose therapy in HIV-infected patients.

Authors:  K Gallicano; J Sahai; E Ormsby; D W Cameron; A Pakuts; I McGilveray
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335

4.  Pharmacokinetics and bioavailability of fluconazole in two groups of males with human immunodeficiency virus (HIV) infection compared with those in a group of males without HIV infection.

Authors:  S Tett; S Moore; J Ray
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.